Pancreatic Cancer Research

ResearcherUniversité Paris CitéActive in the last 2 years

Anne‐Laure Pointet

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110601817. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 6

  1. Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study. Co-author DOI 10.1093/oncolo/oyaf125↗
  2. Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter … Co-author DOI 10.1016/j.clinre.2019.08.009↗
  3. Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma… First author DOI 10.1016/j.ejca.2020.05.018↗
  4. Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study. Co-author DOI 10.1177/1756284819878660↗
  5. Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology. Co-author DOI 10.1007/s11136-015-1198-x↗
  6. Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a mu… Co-author DOI 10.1186/s12885-016-2860-6↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Julien Taı̈eb · 5 shared papers, 2016–2025 · strength 0.42
  2. Isabelle Trouilloud · 3 shared papers, 2019–2025 · strength 0.33
  3. Dominique Béchade · 3 shared papers, 2019–2025 · strength 0.33
  4. Simon Pernot · 3 shared papers, 2019–2025 · strength 0.33
  5. Nicolas Williet · 3 shared papers, 2019–2025 · strength 0.33
  6. David Tougeron · 3 shared papers, 2019–2025 · strength 0.33
  7. Émilie Soularue · 2 shared papers, 2020–2025 · strength 0.26
  8. Franck Bonnetain · 3 shared papers, 2016–2025 · strength 0.25
  9. Jean–Marc Phelip · 2 shared papers, 2019–2025 · strength 0.24
  10. Raëf Abdallah · 1 shared paper, 2025 · strength 0.16
  11. Alix Portal · 1 shared paper, 2025 · strength 0.16
  12. Laëtitia Dahan · 1 shared paper, 2025 · strength 0.16
  13. Camille Evrard · 1 shared paper, 2025 · strength 0.16
  14. Lysiane Marthey · 1 shared paper, 2025 · strength 0.16
  15. Pascal R. Hammel · 1 shared paper, 2025 · strength 0.16
  16. Jean‐Baptiste Bachet · 1 shared paper, 2025 · strength 0.16
  17. Romain Coriat · 1 shared paper, 2025 · strength 0.16
  18. Denis Pezet · 1 shared paper, 2019 · strength 0.08
  19. Aziz Zaanan · 1 shared paper, 2016 · strength 0.05
  20. Momar Diouf · 1 shared paper, 2016 · strength 0.05
  21. David Malka · 1 shared paper, 2016 · strength 0.05
  22. Christelle d’Engremont · 1 shared paper, 2016 · strength 0.05
  23. Déwi Vernerey · 1 shared paper, 2016 · strength 0.05
  24. Christophe Borg · 1 shared paper, 2016 · strength 0.05
  25. Philippe Bachellier · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.